Potential clinical applications for human pluripotent stem cell-derived blood components. - Wikidata - wikimedia - TriplyDB

Potential clinical applications for human pluripotent stem cell-derived blood components.

Potential clinical applications for human pluripotent stem cell-derived blood components.

http://www.wikidata.org/entity/Q37857709

about

Dendritic cells derived from pluripotent stem cells: Potential of large scale production SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells Stem Cell Therapy: A New Treatment for Burns?Advances in meniscal tissue engineering Tissue engineered strategies for skeletal muscle injury SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.Progress and prospects in stem cell therapy.Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.An experimental approach to the generation of human embryonic stem cells equivalents.The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia.

P2860

Q26865622-D25B7EC3-8C61-4393-9FC3-BE9275BEC5E9 Q28298055-54A642FF-4BCF-4BCB-BC8D-15444EF30ACB Q33765265-9CE1B380-BDA2-4923-AF4F-E002A12F1389 Q35495328-B0A9FCCD-6627-4586-99D4-9E7FD16850D8 Q35550814-CCCE745A-B700-4DFE-9B1A-F88B00A08D67 Q35591443-A0C0D653-3EB4-4B14-AF17-C24076EEE940 Q36907411-27D7D20E-C374-41EA-A9B9-EF86FA0F449A Q38007342-FBF39741-DEB5-4D8D-B18E-8061072B6B4A Q38154562-C4D000B8-FD4F-47F7-93E6-70B1B5D9CF5A Q39749114-90CED492-867E-4034-9F5C-A22FEFD4498A

P2860

Potential clinical applications for human pluripotent stem cell-derived blood components.

http://www.wikidata.org/entity/Q37857709

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Potential clinical applications for human pluripotent stem cell-derived blood components.

@en

Potential clinical applications for human pluripotent stem cell-derived blood components.

@nl

type

label

Potential clinical applications for human pluripotent stem cell-derived blood components.

@en

Potential clinical applications for human pluripotent stem cell-derived blood components.

@nl

prefLabel

Potential clinical applications for human pluripotent stem cell-derived blood components.

@en

Potential clinical applications for human pluripotent stem cell-derived blood components.

@nl

P1433

Q37857709-6B8A68A8-A467-480B-BB41-BEA3F1171223

P1476

Q37857709-6D39A8D6-8EA1-4B3C-BEBD-5AB8FB1FCD14

P2093

Q37857709-ACA037EA-7B93-4875-8771-8D027341D22D

Q37857709-BA320117-3EF2-437C-9845-4D0AC86FCD29

P2860

Q37857709-001B8D67-C9DB-4D2A-9D19-FB5E40416EA6

Q37857709-0275C892-B2FA-4629-81EA-3E168077E27F

Q37857709-0F3DABFE-AD7D-4AA4-8A69-39FE37ACCA07

Q37857709-16EE5DA2-93FF-468B-ADA6-1D731443A583

Q37857709-18E9A8B6-8B07-434D-BB0F-F44B4AF672D2

Q37857709-1CB13526-67E5-4696-944E-D6A799325627

Q37857709-1FF00FD3-4A2B-4F17-BA2A-B8BCB0527D4D

Q37857709-218E9E61-51C0-4F55-A1D9-6C14E6EC0B30

Q37857709-2655FA31-6F8D-45B8-AED2-174E8AACD44E

Q37857709-28316171-38E3-4522-BDDE-DA1BEC411773

P304

Q37857709-F3E0A2CB-EF34-4F17-8FD6-69EE727B5B01

P31

Q37857709-7E578944-3C1F-4659-B37F-1556405BE12B

P356

Q37857709-7AC9E6D3-B42A-427C-872A-A5F3A34BC8E0

P478

Q37857709-FF8E8FBF-6FF7-486D-B370-2C6E2B0F937C

P577

Q37857709-55F69E78-DFA7-4AF0-84F1-C3FB8996AF77

P5875

Q37857709-BC470680-4CDE-42DE-95E4-3174CB3710E6

P698

Q37857709-B64F5325-AA68-4E1A-8AA8-96ED45131446

P932

Q37857709-79C3FF16-D9C1-4F80-9FD3-CB9AD89FFE30

P356

P1433

Stem Cells International

P1476

Potential clinical applications for human pluripotent stem cell-derived blood components.

@en

P2093

Erin A Kimbrel

http://www.w3.org/2001/XMLSchema#string

Shi-Jiang Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation

The multiple personalities of the chemokine receptor CCR7 in dendritic cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.

P304

273076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4061/2011/273076

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50851527

http://www.w3.org/2001/XMLSchema#string

P698

21437192

http://www.w3.org/2001/XMLSchema#string

P932

3062143

http://www.w3.org/2001/XMLSchema#string